Hi-Tech Pharmacal (NASDAQ: HITK) and Teva Pharmaceutical Industries Limited (NYSE:TEVA) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, earnings, institutional ownership, risk, analyst recommendations and profitability.

Profitability

This table compares Hi-Tech Pharmacal and Teva Pharmaceutical Industries Limited’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Hi-Tech Pharmacal N/A N/A N/A
Teva Pharmaceutical Industries Limited -25.18% 15.96% 5.31%

Valuation and Earnings

This table compares Hi-Tech Pharmacal and Teva Pharmaceutical Industries Limited’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio NetIncome Earnings Per Share Price/Earnings Ratio
Hi-Tech Pharmacal N/A N/A N/A N/A N/A
Teva Pharmaceutical Industries Limited $21,903.00 0.00 $329.00 ($6.12) N/A

Teva Pharmaceutical Industries Limited has higher revenue and earnings than Hi-Tech Pharmacal.

Insider & Institutional Ownership

56.6% of Teva Pharmaceutical Industries Limited shares are held by institutional investors. 7.1% of Teva Pharmaceutical Industries Limited shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Dividends

Teva Pharmaceutical Industries Limited pays an annual dividend of $0.94 per share. Hi-Tech Pharmacal does not pay a dividend. Teva Pharmaceutical Industries Limited pays out -15.4% of its earnings in the form of a dividend.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Hi-Tech Pharmacal and Teva Pharmaceutical Industries Limited, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hi-Tech Pharmacal 0 0 0 0 N/A
Teva Pharmaceutical Industries Limited 4 17 5 0 2.04

Summary

Teva Pharmaceutical Industries Limited beats Hi-Tech Pharmacal on 7 of the 8 factors compared between the two stocks.

Hi-Tech Pharmacal Company Profile

Hi-Tech Pharmacal Co., Inc. is a specialty manufacturer and marketer of prescription, over-the-counter and nutritional products. The Company develops, manufactures and markets products in three categories: generics, prescription brands and over-the-counter (OTC) brands. It produces a range of products for various disease states, including glaucoma, asthma, bronchial disorders, dermatological disorders, allergies, pain, stomach, oral care and other conditions. The Company’s generic products are primarily prescription items and include oral solutions and suspensions, topical creams and ointments as well as nasal sprays. It also specializes in the manufacture of products in its sterile facility capable of producing liquid ophthalmic, otic and inhalation products. In April 2014, Akorn Inc acquired Hi-Tech Pharmacal Co., Inc.

Teva Pharmaceutical Industries Limited Company Profile

Teva Pharmaceutical Industries Limited is a pharmaceutical company. The Company is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. The Company operates through two segments: Generic medicines and Specialty medicines. The Company develops, manufactures and sells generic medicines in a range of dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments and creams. Its specialty medicines business focuses on delivering a range of solutions to patients and providers through medicines, devices and services in various regions and markets around the world. Its specialty medicines business includes its core therapeutic areas of central nervous system (CNS) and respiratory medicines with a focus on asthma and chronic obstructive pulmonary disease. It also has specialty products in oncology, women’s health and selected other areas.

Receive News & Ratings for Hi-Tech Pharmacal Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hi-Tech Pharmacal Co. and related companies with Analyst Ratings Network's FREE daily email newsletter.